YOU SEARCHED BY...
Company Spotlight
Cytovance Biologics
Contract Service Directory
Sandoz GmbH
Company Headquarters
Biochemie Str. 10
Kundl, A-6250
Austria
Contract Service Directory
- Biologics Manufacturing
- Biologics Process Development
- Contract Development and Manufacturing Organization (CDMO)
- Contract Manufacturing
- Downstream Processing
- Drug Development Services
- Fermentation
- Lyophilization
- Manufacturing, API
- Manufacturing, Clinical Trials Supply
- Manufacturing, Injectables
- Manufacturing, Peptides
- Manufacturing, Proteins
- Parenterals, Vial Filling
- Process Development/Scale-Up Services
- Protein Extraction/Purification
- Purification
- Scale-Up
- Technology Transfer
Contract Services Directory
Related Content
-
Bio News | Biosimilars
Know the Challenges of Biosimilar Manufacturing
Best Practices for a Competitive MarketJerry Martin, Pharmaceutical and Life Sciences Consultant to PMMI, and, Dr. Michiel Ultee, Principal, Ulteemit BioConsulting, LLC 04.11.18
-
Clinical Trials | CRO News | Information Technology
Chiltern Releases Medidata Rave Value Accelerators
Tools capture, manage and report clinical research data06.08.17
-
Breaking News | Drug Delivery | Industry News | Inspections
Tapemark Passes Regulatory Hurdle
Manufacturing facility completes successful FDA pre-approval and general GMP inspection06.07.17
-
Biologics, Proteins, Vaccines
Trends in New Technologies & Budgets
Budget increases in biopharmaceutical industry indicate future growthEric S. Langer, BioPlan Associates 06.06.17
-
Inspections | Regulatory Affairs
-
Biologics, Proteins, Vaccines | Biosimilars | cGMP Manufacture
Biopharmaceutical Contract Manufacturing Market
The market continues to grow, projected to exceed $4 billion in 2017William Downey, President, HighTech Business Decisions 06.06.17
-
Breaking News | Industry News | Inspections
-
Breaking News | Facilities | Industry News | Inspections
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Clinical Trials | Industry News
Kemwell Provides Services for U.S. Trial
Supplies biologics drug substance for phase 1 clinical trials for U.S. IND filing05.18.17
-
Regulatory Affairs
The FDA and Metrics
The Agency and industry continue to work together to achieve FDA’s objectivesDavid Lonza, Lachman Consultant Services, Inc. 05.09.17
-
Trump Picks New FDA Commish
Combatting high drug prices and overregulation likely to be high on agendaTim Wright, Editor 04.03.17
-
-
Capsules | Solid Dosage/Semi-solids
Generic Drug Trends
Industry faces tighter capacity, consolidation, and drug pricing uncertaintyEdward S. Price, President, PCI 03.07.17
-
Aseptic Processing | Bio News | Breaking News | Facilities | Fill/Finish | Industry News | Inspections | Lyophilization
LSNE Completes Two FDA Inspections
FDA PAI and general GMP inspection of two aseptic manufacturing plants and QC laboratory completed successfully03.06.17
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
Sanofi and Lonza in $285mn Biologics Pact
A large-scale facility, to be built in Visp, Switzerland, will be established through a joint venture03.06.17
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Promotions & Moves
CrownBio Expands Life Science Division
Will expand product portfolio; names Debby Saunders executive director01.30.17
-
QA/QC | Regulatory Affairs
FDA’s Quality Agreements Guidance
Evaluation of FDA’s recently issued Contract Manufacturing Arrangements for Drugs: Quality Agreements Guidance for IndustryPaul Mason, Ph.D., Director of Lachman Consultant Services, Inc. 01.26.17
-
cGMP Manufacture | Industry News
Biofortuna Expands Immunoassay Services
Invests in production capabilities for immunoassay design, development and manufacture01.25.17
-
Ten Tips for Single-Use Tubing Selection
Download this paper for suggestions on narrowing your choices.
